Calvenza™ EHV

BOEHRINGER INGELHEIM

Description

Calvenza™ EHV is equine rhinopneumonitis vaccine killed virus vaccine. For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in the reduction of respiratory disease due to equine herpesvirus type 1 (EHV-1) and type 4 (EHV-4).
Benefits:
  • Proven safe
  • Minimal vaccine site reactions
  • Three dose regiment conforms to AAEP recommendations
  • Flexible dose administration
Additional Information
DEA
Hazmat - Chargeable
Ice
List 1
MSDS
My eCustom Catalog
Hazmat - No Charge
Pedigree
Prescription
Promotion
This item is on your Formulary list.
New Arrivals